Am J Transplant, Volume 21, Suppl 3 Archives - Page 112 of 139 - ATC Abstracts

2021 American Transplant Congress
Combined Impact of Pre-sensitization and Delayed Graft Function on Allograft Rejection in Deceased Donor Kidney Transplantation: A Nationwide Cohort Study
H. Lee¹, Y. Park¹, T. Ban², S. Song³, S. Song⁴, J. Yang⁵, C. Ahn⁵, C. Yang¹, B. Chung¹
¹Division of Nephrology, Department of Internal Medicine, Seoul St. Mary’s hospital, Seoul, Korea, Republic of, ²Division of Nephrology, Department of Internal Medicine, Eunpyeong St. Mary’s hospital, Seoul, Korea, Republic of, ³Organ Transplantation Center and Department of Internal Medicine, Pusan National University Hospital, Pusan, Korea, Republic of, ⁴Department of Surgery, Ewha Womans University Medical Center, Seoul, Korea, Republic of, ⁵Department of Nephrology, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: The aim of this study is to investigate whether or not delayed graft function (DGF) and pre-transplant sensitization has a synergistic adverse effect on…
2021 American Transplant Congress
Clazakizumab (clz, Anti-il-6 Antibody) Treatment Affects Il-6/il-6r Signaling by Increasing Soluble Gp130 (sgp130) in Hla-sensitized Kidney Transplant Patients (hs Ktx Pts) Treated for Chronic Antibody-mediated Rejection (cabmr)
B. Shin, S. Ge, A. Jimenez, N. Ammerman, A. Vo, R. Zhang, S. C. Jordan, M. Toyoda
Cedars-Sinai Medical Center, Cerritos, CA
*Purpose: IL-6 is a pro-inflammatory cytokine responsible for chronic vascular inflammation and a promising target for cABMR modulation. IL-6/sIL-6R complex initiates more pathogenic trans-signaling pathways…
2021 American Transplant Congress
PLA2R Status and Antibody Mediated Rejection in Kidney Transplant with Membranous Nephropathy
H. S. Han¹, A. Urisman², J. Shoji¹
¹Kidney Transplant Service, University of California, San Francisco, San Francisco, CA, ²Pathology, University of California, San Francisco, San Francisco, CA
*Purpose: Membranous nephropathy (MN) in transplanted kidney is categorized as de novo or recurrent disease. This immune complex glomerulopathy presents with varying levels of proteinuria,…
2021 American Transplant Congress
Biliary Complications Following Adult Deceased Donor Liver Transplantation: Risk Factors and Implications at a High-Volume US Center
A. Matar, K. Ross-Driscoll, L. Kenney, H. Wichmann, J. F. Magliocca, W. H. Kitchens
Emory Transplant Center, Atlanta, GA
*Purpose: Biliary leaks and anastomotic strictures comprise the majority of biliary complications (BCs) following liver transplantation. Most case series of BCs in adult deceased donor…
2021 American Transplant Congress
Blood Pressure Variability Immediately After Liver Transplant Predicts the Likelihood of Long-Term Cardiovascular Events
K. N. Truitt¹, K. Chen², Y. Yano³, D. Gregory⁴, L. B. VanWagner⁵
¹Northwestern Memorial Hospital, Chicago, IL, ²Harvard University, Cambridge, MA, ³Duke University School of Medicine, Durham, NC, ⁴Northwestern University Feinberg School of Medicine, Chicago, IL, ⁵Northwestern University Feinberg School of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
*Purpose: Cardiovascular disease is a leading cause of mortality in liver transplant recipients (LTRs). Adequate blood pressure (BP) control within one year after liver transplant…
2021 American Transplant Congress
A Shift in Paradigm: Phosphatidylethanol Testing to Monitor for and Address Alcohol Recidivism Following Liver Transplantation
F. M. Nimri¹, S. Naffouj¹, F. Askar¹, A. Singh², H. Gonzalez², S. Jafri²
¹Internal Medicine, Henry Ford Hospital, Detroit, MI, ²Gastroenterology, Henry Ford Hospital, Detroit, MI
*Purpose: Phosphatidylethanol (PEth) is a phospholipid that forms in the presence of ethanol with a long half-life compared to other alcohol detection tests. PEth testing…
2021 American Transplant Congress
Outcomes of Surgical Resection versus Liver Transplantation in Hilar Cholangiocarcinoma
M. K. White¹, F. Aucejo², A. Moro², K. Sasaki², K. Stephans³, B. Estfan⁴, C. Quintini², B. Eghtesad², K. Hashimoto², F. Masato², C. Miller², K. Menon⁵
¹Cleveland Clinic, Cleveland, OH, ²General Surgery, Cleveland Clinic, Cleveland, OH, ³Radiation Oncology, Cleveland Clinic, Cleveland, OH, ⁴Oncology, Cleveland Clinic, Cleveland, OH, ⁵Gastroenterology & Hepatology, Cleveland Clinic, Cleveland, OH
*Purpose: To compare the outcomes of patients with hilar cholangiocarcinoma (hCCA) who underwent either surgical resection or liver transplantion (LT).*Methods: All hCCA patients who underwent…
2021 American Transplant Congress
Center Cost is Not a Barrier to Aggressive Utilization of DCD Livers
L. M. Brewer, D. M. Faulkner, A. J. Logan, J. M. Sneddon, G. N. Brock, N. Singh, W. K. Washburn, A. D. Schenk
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Only 7% of livers transplanted in 2018 were from deceased from cardiac death (DCD) donors and only a minority of transplant centers aggressively utilize…
2021 American Transplant Congress
Evaluation of Increasing Liver Discard Rate and Waiting List Drop-Off in Post-MELD Era
R. Matsumoto¹, K. Halazun², J. Emond¹, B. Samstein², R. S. Brown Jr.², L. Dove¹, T. Kato¹
¹Center for Liver Disease and Transplantation, Columbia University Irving Medical Center, New York, NY, ²Center for Liver Disease and Transplantation, Weill Cornell Medical Center, New York, NY
*Purpose: As number of donors and transplant cases rises each year, it is important to evaluate not only post-transplant survival rate but also the organ…
2021 American Transplant Congress
Comparison of Outcomes of Living Donor Liver Transplantation for Biliary Atresia Patients with and without Kasai Portoenterostomy
T. Kanmaz¹, O. Andacoglu¹, Y. Yankol², C. Karatas¹, N. Mecit¹, K. Acarli³, M. Kalayoglu¹
¹Koc University, Istanbul, Turkey, ²University of Wisconsin, Madison, WI, ³Memorial Hospital, Istanbul, Turkey
*Purpose: We evaluated 10 year outcomes and the potential predictors of outcomes after living donor liver transplant (LT) for biliary atresia (BA) patients with and…